Abstract
Background: Access to health care is important for prostate cancer (CaP) screening and control. There is evidence of the racial disparities in health access of black men and Hispanics; however, the comparison between black men's access to health in the United States and those in Africa has not been fully elucidated. Aim: This study aims to evaluate health access and willingness to screen for CaP among black men in Nigeria, Cameroon, and United States. Methods: The Prostate Cancer Transatlantic Consortium (CaPTC) family cohort study phase 1 data of 500 community-dwelling black men in Nigeria, Cameroon, and the United States between 35 and 70 years were used in this study. The association between healthcare access and the willingness to screen for CaP was assessed. The data were described using numbers and percentages; Chi-square was used to test for the association between healthcare access and willingness to screen for CaP. P-values < 0.05 was set as significant. Results: The study showed that 86.1% were from Nigeria, 6.1% from Cameroon, and 7.8% from the United States. Most (75.6%) had never had prostate specific antigen (PSA) screening, and 87.8% had never had digital rectal examination (DRE). Willingness to screen was found in 36.8%, while 11.6% could not decide to screen; 27.4% and 33% were willing to screen for DRE and PSA, respectively. Majority (83.8%) had no access to medical doctors in the last 12 months, and the country of residence was not found to improve access to health (p= 0.378). Healthcare insurance coverage was more available to the US participants with 68.4%, 42.9% in Nigeria, and 16.7% in Cameroon. Overall willingness to screen, willingness for DRE and PSA screening were significantly associated with the country of residence with p-values of 0.02, <0.01, and <0.01, respectively. Having healthcare coverage was also associated with overall willingness to screen (p=0.033). Conclusions: The study showed that country of residence was not associated with health access; however, willingness for CaP screening was significantly associated with the country of residence and healthcare insurance coverage.
Citation Format: Opeyemi O. Bolajoko, Catherine A. Oladoyinbo, Folakemi T. Odedina. Health access and willingness to screen for prostate cancer among black men in Nigeria, Cameroon, and United States [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr A098.